Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renoprotective effects of ursodeoxycholic acid in type 1 diabetes with albuminuria
2015-003609-41Phase 4Unknown
- Sponsor
- King's College London
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ursodeoxycholic acid in diabetes mellitus type 1 (T1D), diabetic glomerulosclerosis and albuminuria (2 arms), sponsored by King's College London. Primary endpoint: Change in albumin excretion rate. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
diabetes mellitus type 1 (T1D)diabetic glomerulosclerosisalbuminuria
Beyond the preview
Go deeper on 2015-003609-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003609-41.